In the last couple of weeks there has been on a lot of chatter on the gloomy situation of telehealth companies. Teladoc’s stock is down >70% from its peak in Jan 21 from $287 to <$75 and AmWell has had a ~90% (!) drop from $42.8 to <$4.5 (as of Feb 8th). Pieces like “
3
Much has been said about the huge potential Israel has as a digital health powerhouse. One of the most common arguments is the breadth and depth of data…
1
Or the customer segment that can’t be ignored any more
7
A quick and dirty summary of 2021 and some future outlook for Israeli companies
1
A tale of selling drugs with software margins
2
There are few things more annoying than finishing an episode of your favorite Netflix show only to start the next episode and have no idea what’s going…
2
Market conditions offer Israeli companies the opportunity to play a bigger role in the booming industry, as long as they get their formulas right.
2
Opportunities around value based care and the Israeli angle
2
See all

"Differential Diagnosis" / Digital Health by Arkin Holdings